GlycoFlux™ Human ST6GALNAC1 Overexpression Raji Cell Line (CAT#: GLJF-0925-JF1135)

Description	GlycoFlux™ human ST6GALNAC1 overexpression Raji cell line is a stable cell line engineered to overexpress ST6GALNAC1, a sialyltransferase that modifiesO-linked GalNAc residues to generate the cancer-associated sialyl-Tn antigen. This model is widely applicable in tumor immunology, glycan biomarker discovery, and studies of altered cell-cell interactions in malignancies.
Product Type	Overexpression Cell Lines
Species	Human
Cell Morphology	Lymphoblast-like, suspension growth
Passage Ratio	1:2~1:4
Cell Line	Raji
Primary Disease	Burkitt's lymphoma
Lineage	B lymphocyte (B cell)
Lineage Subtype	Mature B cell, widely used in EBV-related studies

Cell Viability	>90%
Sterility Test	The sterility test indicated an absence of microbial growth.
Identity Test	STR identification
Mycoplasma Test	Negative
Virus Test	Negative for HIV, HBV and HCV.
Genetic Stability Testing	We conduct cell genetic stability studies in full compliance with ICH guidelines. Our expertise enables us to design and execute a comprehensive testing program tailored to your specific needs and regulatory requirements.
Validation	qPCR, Sanger Sequencing
Culture Medium	FBS & RPMI
Application	Mechanistic studies; Exploration of glycosylation and signaling pathways in cancer, metabolic, and immune-related diseases; Drug target validation and other functional assays.
Size	1 M cells/vial*2
Product Format	Frozen
Shipping	Dry ice
Availability Status	Made to order
Handling Notes	Upon receipt, this product must be immediately transferred from dry ice to liquid nitrogen (-150°C to -190°C) and stored in a liquid nitrogen tank. Cell viability is critically dependent on proper handling. We cannot guarantee viability if these instructions are not strictly adhered to.
Product Disclaimer	This product is provided for research only, not suitable for human or animal use. Due to the inherent limitations of infectious agent testing, investigators must exercise extreme caution when handling cells provided by Creative Biolabs, treating all cells as potentially biohazardous.

Target	ST6GALNAC1
Full Name	ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1
Alternative Name	SIAT7A; ST6GalNAcI
Location	17q25.1
Gene ID	55808
Summary	Transfers sialic acid to O-linked GalNAc residues, forming the cancer-associated sialyl-Tn antigen and affecting cell-cell interactions.